Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension

British Journal of Clinical Pharmacology

Volumn 52, Issue 6, 2001, Pages 687-692

  Lefrandt, Johan D ^a   Heitmann, Jörg ^b   Sevre, Knut ^c   Castellano, Maurizio ^d   Hausberg, Martin ^e   Fallon, Maura ^f   Urbigkeit, Anja ^b   Rostrup, Morten ^c   Agabiti Rosei, Enrico ^d   Rahn, Karl H ^e   Murphy, Michael ^f   Zannad, Faiez ^g   De Kam, Pieter Jan ^a   Smit, Andries J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BRESCIA   (Italy)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f University College Cork and INFANT Centre   (Ireland)

^g Ctr Hospitalier Univ de Nancy   (France)

Author keywords

Amlodipine; Noradrenaline; Rate pressure product; Stress responses; Verapamil

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; NORADRENALIN; VERAPAMIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HAND GRIP; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE;

EID: 0035675720     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01507.x     Document Type: Article

References (25)

1. Hyperkinetic borderline hypertension in Tecumseh, Michigan
2. Reduced cardiovascular efficiency and increased reactivity during exercise in borderline and established hypertension
3. Predictors of stable hypertension in young borderline subjects: A five-year follow-up study
4. Role of blood pressure response to provocative tests in the prediction of hypertension in adolescents
5. Transition from high cardiac output to elevated vascular resistance in hypertension
6. The heart in hypertension
7. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
8. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
9. Impairment of flow-dependent coronary dilation in hypertensive patients. Demonstration by cold pressor test induced flow velocity increase
10. Coronary artery constriction caused by the cold pressor test in human hypertension
11. Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring
12. Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontier
13. Calcium antagonists. Pharmacologic differences and similarities
14. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications
15. Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses
16. Electrophysiologic assessment of calcium channel blockers in transplanted hearts: An experimental study
17. Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise
18. Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus
19. Pharmacology of calcium entry blockers: Interaction with vascular alpha-adrenoceptors
20. The effect of verapamil on cardiac sympathetic function
21. The effect of calcium channel blockers on the H (+)-ATPase and bioenergetics of catecholamine storage vesicles
22. Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: Effect of verapamil
23. Validation of myocardial oxygen demand indices in patients awake and during anesthesia
24. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris
25. Effect of verapamil on mortality and major events after acute myocardial infarction DAVIT II